These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29289789)

  • 1. Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis.
    Messer JG; Mendieta Calle JL; Jiron JM; Castillo EJ; Van Poznak C; Bhattacharyya N; Kimmel DB; Aguirre JI
    Bone; 2018 Mar; 108():79-88. PubMed ID: 29289789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.
    Messer JG; Jiron JM; Mendieta Calle JL; Castillo EJ; Israel R; Phillips EG; Yarrow JF; Van Poznak C; Kesavalu L; Kimmel DB; Aguirre JI
    Oral Dis; 2019 May; 25(4):1116-1135. PubMed ID: 30712276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.
    Aguirre JI; Akhter MP; Kimmel DB; Pingel JE; Williams A; Jorgensen M; Kesavalu L; Wronski TJ
    J Bone Miner Res; 2012 Oct; 27(10):2130-43. PubMed ID: 22623376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris).
    Castillo EJ; Messer JG; Abraham AM; Jiron JM; Alekseyenko AV; Israel R; Thomas S; Gonzalez-Perez GM; Croft S; Gohel A; Bhattacharyya I; Yarrow JF; Novince CM; Kimmel DB; Aguirre JI
    Bone; 2021 Apr; 145():115866. PubMed ID: 33515777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats.
    Castillo EJ; Jiron JM; Croft CS; Freehill DG; Castillo CM; Kura J; Yarrow JF; Bhattacharyya I; Kimmel DB; Aguirre JI
    Front Med (Lausanne); 2023; 10():1179350. PubMed ID: 37404809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris).
    Messer JG; Castillo EJ; Abraham AM; Jiron JM; Israel R; Yarrow JF; Thomas S; Reynolds MC; Wnek RD; Jorgensen M; Wanionok N; Van Poznak C; Bhattacharyya I; Kimmel DB; Aguirre JI
    Bone; 2020 Jan; 130():115141. PubMed ID: 31707108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
    Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
    [No Abstract]   [Full Text] [Related]  

  • 8. The Preventive Effect of Preoperative and Postoperative Selenium on the Medication-Related Osteonecrosis of the Jaw: An Animal Study in Rats.
    Isleyen M; Cina M; Asci H; Ilhan I; Oguz Yuceer R
    J Oral Maxillofac Surg; 2024 Jul; 82(7):828-839. PubMed ID: 38621662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Food Impaction-Induced Periodontitis in Conventionally Housed Marsh Rice Rats (
    Messer JG; Jiron JM; Chen HY; Castillo EJ; Mendieta Calle JL; Reinhard MK; Kimmel DB; Aguirre JI
    Comp Med; 2017 Feb; 67(1):43-50. PubMed ID: 28222838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: A major adverse effect of bisphosphonate therapy.
    Tamari T; Elimelech R; Cohen G; Cohen T; Doppelt O; Eskander-Hashoul L; Zigdon-Giladi H
    Sci Rep; 2019 Dec; 9(1):18896. PubMed ID: 31827217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model.
    Otto S; Pautke C; Arens D; Poxleitner P; Eberli U; Nehrbass D; Zeiter S; Stoddart MJ
    J Bone Miner Res; 2020 Nov; 35(11):2179-2192. PubMed ID: 32568416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of zoledronic acid on the progression of experimental periodontitis in rats: histological and microtomographic analyses.
    Leite de Marcelos PGC; Perez DEDCP; Soares DM; de Araújo SS; Evêncio LB; Pontual MLDA; Ramos-Perez FMM
    J Periodontal Implant Sci; 2021 Aug; 51(4):264-275. PubMed ID: 34387046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling.
    de Sousa Ferreira VC; Lopes AP; Alves NM; Sousa FRN; Pereira KMA; Gondim DV; Girão VCC; Leitão RFC; Goes P
    Clin Oral Investig; 2021 Feb; 25(2):673-682. PubMed ID: 32897500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in macrophage polarization in the craniofacial and extracranial skeleton after zoledronate application and surgical interventions - an
    Struckmeier AK; Wehrhan F; Preidl R; Mike M; Mönch T; Eilers L; Ries J; Trumet L; Lutz R; Geppert C; Kesting M; Weber M
    Front Immunol; 2023; 14():1204188. PubMed ID: 37292209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
    Ikesue H; Mouri M; Tomita H; Hirabatake M; Ikemura M; Muroi N; Yamamoto S; Takenobu T; Tomii K; Kawakita M; Katoh H; Ishikawa T; Yasui H; Hashida T
    Support Care Cancer; 2021 Aug; 29(8):4763-4772. PubMed ID: 33527228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Ligature-Induced Periodontitis Exacerbates Development of Bisphosphonate-Related Osteonecrosis of the Jaw in Mice.
    Williams DW; Ho K; Lenon A; Kim S; Kim T; Gwack Y; Kim RH
    J Bone Miner Res; 2022 Jul; 37(7):1400-1410. PubMed ID: 35598324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats.
    Vitale M; Corrêa MG; Ervolino E; Cirano FR; Ribeiro FV; Monteiro MF; Casati MZ; Pimentel SP
    Oral Dis; 2024 Apr; 30(3):1462-1474. PubMed ID: 36807967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
    Zhao N; Li QX; Wang YF; Qiao Q; Huang HY; Guo CB; Guo YX
    BMC Oral Health; 2023 May; 23(1):330. PubMed ID: 37245004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid.
    Wei LY; Kok SH; Lee YC; Chiu WY; Wang JJ; Cheng SJ; Chang HH; Lee JJ
    J Formos Med Assoc; 2021 Aug; 120(8):1572-1580. PubMed ID: 33309430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.